Dec 13, 2021 Cellectar Presented Data from its Ongoing Phase 2 CLOVER-1 Study of Iopofosine I-131 at the 63rd ASH Annual Meeting and Exposition Learn More
Dec 8, 2021 Cellectar Biosciences Announces Poster Presentation at the 63rd American Society for Hematology Annual Meeting and Exposition Learn More
Nov 16, 2021 Cellectar’s Iopofosine I-131 Exhibits Signals of Efficacy in Phase I Study for Pediatric Brain and Solid Tumors Learn More
Nov 8, 2021 Cellectar Reports Financial Results for the Third Quarter 2021 and Provides a Corporate Update Learn More